scholarly journals Stable, Metastable, and Kinetically Trapped Amyloid Aggregate Phases

2014 ◽  
Vol 16 (1) ◽  
pp. 326-335 ◽  
Author(s):  
Tatiana Miti ◽  
Mentor Mulaj ◽  
Jeremy D. Schmit ◽  
Martin Muschol
Keyword(s):  
2018 ◽  
Vol 5 (2) ◽  
pp. 171399 ◽  
Author(s):  
Lisa-Maria Needham ◽  
Judith Weber ◽  
James W. B. Fyfe ◽  
Omaru M. Kabia ◽  
Dung T. Do ◽  
...  

Protein aggregation into amyloid deposits and oxidative stress are key features of many neurodegenerative disorders including Parkinson's and Alzheimer's disease. We report here the creation of four highly sensitive bifunctional fluorescent probes, capable of H 2 O 2 and/or amyloid aggregate detection. These bifunctional sensors use a benzothiazole core for amyloid localization and boronic ester oxidation to specifically detect H 2 O 2 . We characterized the optical properties of these probes using both bulk fluorescence measurements and single-aggregate fluorescence imaging, and quantify changes in their fluorescence properties upon addition of amyloid aggregates of α-synuclein and pathophysiological H 2 O 2 concentrations. Our results indicate these new probes will be useful to detect and monitor neurodegenerative disease.


Prion ◽  
2020 ◽  
Vol 14 (1) ◽  
pp. 118-128 ◽  
Author(s):  
Polina B. Drozdova ◽  
Yury A. Barbitoff ◽  
Mikhail V. Belousov ◽  
Rostislav K. Skitchenko ◽  
Tatyana M. Rogoza ◽  
...  

Biomaterials ◽  
2020 ◽  
Vol 255 ◽  
pp. 120165 ◽  
Author(s):  
Jinhyeong Jang ◽  
Kayoung Kim ◽  
Jaeho Yoon ◽  
Chan Beum Park

2015 ◽  
Vol 3 (35) ◽  
pp. 7055-7067 ◽  
Author(s):  
Xianbo Zhou ◽  
Chengwen Cao ◽  
Qingchang Chen ◽  
Qianqian Yu ◽  
Yanan Liu ◽  
...  

Human islet amyloid polypeptide (hIAPP) was found as amyloid aggregate deposits in the pancreatic islets of patients with type-2 diabetes and studies showed that insulin and its derivatives were the potent inhibitors of hIAPP aggregation.


2021 ◽  
Vol 7 (13) ◽  
pp. eabf9180
Author(s):  
A. Duro-Castano ◽  
C. Borrás ◽  
V. Herranz-Pérez ◽  
M. C. Blanco-Gandía ◽  
I. Conejos-Sánchez ◽  
...  

Alzheimer’s disease (AD), the most prevalent form of dementia, remains incurable mainly due to our failings in the search for effective pharmacological strategies. Here, we describe the development of targeted multimodal polypeptide-based nanoconjugates as potential AD treatments. Treatment with polypeptide nanoconjugates bearing propargylamine moieties and bisdemethoxycurcumin or genistein afforded neuroprotection and displayed neurotrophic effects, as evidenced by an increase in dendritic density of pyramidal neurons in organotypic hippocampal culture. The additional conjugation of the Angiopep-2 targeting moiety enhanced nanoconjugate passage through the blood-brain barrier and modulated brain distribution with nanoconjugate accumulation in neurogenic areas, including the olfactory bulb. Nanoconjugate treatment effectively reduced neurotoxic β amyloid aggregate levels and rescued impairments to olfactory memory and object recognition in APP/PS1 transgenic AD model mice. Overall, this study provides a description of a targeted multimodal polyglutamate-based nanoconjugate with neuroprotective and neurotrophic potential for AD treatment.


Sign in / Sign up

Export Citation Format

Share Document